valneva se glp-1 receptor agonist weight management diabetes treatments Agonists as for Type 2 Weight Reduction with GLP-1 Agonists
Description
Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors
Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells
Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time
Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition
Please use caution if you have allergies or sensitivities to any of the listed ingredients
